Statements (366)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
gptkb:hospital gptkb:fictional_species gptkb:Genetics gptkb:enemy gptkb:computer gptkb:Biology |
| gptkbp:affects |
gptkb:humans
livestock wild animals immune system any age group |
| gptkbp:affiliation |
gptkb:Hydra
|
| gptkbp:amended_by |
gptkb:1975
gptkb:1992 gptkb:2007 gptkb:2019 |
| gptkbp:appearance |
gptkb:humanoid
|
| gptkbp:appears_in |
gptkb:Marvel's_Agents_of_S._H._I._E._L._D.
|
| gptkbp:applies_to |
symptoms
diseases injuries health conditions |
| gptkbp:associated_with |
gptkb:Oncology
gptkb:neurodegenerative_diseases abdominal pain vomiting diarrhea infections graft failure increased mortality risk autoimmune disorders |
| gptkbp:biological_agent |
Category A agent
|
| gptkbp:breeding_range |
1q21
|
| gptkbp:can_be_chronic |
in nature
|
| gptkbp:can_be_difficult_to_treat_due_to |
lack of insight
|
| gptkbp:can_involve |
self-harm
fabrication of symptoms exaggeration of symptoms faking illness |
| gptkbp:can_lead_to |
hospitalization
legal issues unnecessary medical treatment |
| gptkbp:can_result_in |
emotional distress
serious health complications |
| gptkbp:cause |
gptkb:deception
|
| gptkbp:caused_by |
gptkb:Bacillus_anthracis
glucocerebrosidase deficiency transplantation of tissue E. coli infection |
| gptkbp:challenges |
healthcare providers
|
| gptkbp:character_type |
gptkb:Zombie
|
| gptkbp:characteristic |
gptkb:advanced_technology
|
| gptkbp:clinical_trial |
fatigue
ongoing completed phase 1 phase 2 phase 3 pallor petechiae anuria ongoing research for treatments various ongoing clinical trials oliguria purpura |
| gptkbp:collaborated_with |
academic institutions
international organizations non-governmental organizations |
| gptkbp:collaborates_with |
hospitals
research institutions |
| gptkbp:common_pathogen |
gptkb:Campylobacter_jejuni
Shiga toxin-producing E. coli Salmonella spp. |
| gptkbp:community_health |
gptkb:zoo
foodborne illness outbreaks bioterrorism threat |
| gptkbp:complication |
hypertension
chronic kidney disease neurological complications |
| gptkbp:composed_of |
chapters
sections subcategories codes |
| gptkbp:condition |
gptkb:Fabry_disease
gptkb:Niemann-Pick_disease gptkb:Krabbe_disease Acute Kidney Injury Thrombotic Thrombocytopenic Purpura |
| gptkbp:contains |
diagnostic codes
|
| gptkbp:death |
high in untreated cases
lower with treatment higher in elderly patients low in children with treatment |
| gptkbp:developed_by |
gptkb:World_Health_Organization
|
| gptkbp:diagnosis |
blood tests
genetic testing urine tests clinical evaluation biopsy chest X-ray enzyme assay triad of symptoms skin examination other medical conditions biochemical testing molecular genetic testing |
| gptkbp:discovered_by |
gptkb:19th_century
|
| gptkbp:diseases |
gptkb:anemia
brucellosis Europe in the 19th century Iraq in the 2000s Q fever South Africa in the 1990s |
| gptkbp:disorder_category |
gptkb:diabetes
lysosomal storage disorder |
| gptkbp:education |
patient education is crucial
healthcare provider training is important |
| gptkbp:enemy |
gptkb:S._H._I._E._L._D.
|
| gptkbp:epidemiology |
more common in children
associated with outbreaks |
| gptkbp:facilitates |
clinical decision making
epidemiological research international health statistics health policy planning |
| gptkbp:faction |
The Vampires
The Ghouls The HMHVV Infected |
| gptkbp:first_appearance |
Season 6 of Marvel's Agents of S. H. I. E. L. D.
|
| gptkbp:first_described_by |
gptkb:Philippe_Gaucher
gptkb:1955 ancient times |
| gptkbp:first_published |
1893
1948 |
| gptkbp:genetic_studies |
certain genetic mutations
|
| gptkbp:geographic_distribution |
worldwide
found worldwide |
| gptkbp:goal |
conquer Earth
|
| gptkbp:has_type |
gptkb:Special_Infected
gptkb:Common_Infected |
| gptkbp:historical_significance |
gptkb:2001_anthrax_attacks
gptkb:biological_warfare first lysosomal storage disorder identified important for understanding enzyme deficiencies led to advancements in genetic research |
| gptkbp:homeworld |
gptkb:chronicle
|
| https://www.w3.org/2000/01/rdf-schema#label |
disease
|
| gptkbp:includes |
gptkb:ICD-10
gptkb:ICD-9 disease classifications |
| gptkbp:includes_codes_for |
chronic diseases
infectious diseases mental disorders |
| gptkbp:incubation_period |
1 to 7 days
|
| gptkbp:inherits_from |
autosomal recessive
|
| gptkbp:is_a_complex_condition_that |
requires careful diagnosis.
|
| gptkbp:is_a_form_of |
self-induced illness
|
| gptkbp:is_adopted_by |
gptkb:governments
many countries member states of WHO |
| gptkbp:is_affected_by |
social isolation
|
| gptkbp:is_based_on |
medical knowledge
|
| gptkbp:is_characterized_by |
falsification of medical or psychological symptoms
|
| gptkbp:is_common_in |
gptkb:French_Canadians
gptkb:Ashkenazi_Jews women than men Iberian Peninsula populations |
| gptkbp:is_critical_for |
gptkb:Health_Insurance
resource allocation healthcare planning disease surveillance |
| gptkbp:is_different_from |
malingering
|
| gptkbp:is_essential_for |
patient safety
clinical research disease prevention strategies healthcare quality assessment public health reporting public health planning clinical documentation disease surveillance healthcare reimbursement |
| gptkbp:is_influential_in |
global health policy
|
| gptkbp:is_integrated_with |
electronic health records
healthcare systems |
| gptkbp:is_maintained_by |
gptkb:World_Health_Organization
|
| gptkbp:is_motivated_by |
desire for attention
|
| gptkbp:is_not_well_understood |
by the general public
|
| gptkbp:is_often_associated_with |
psychological issues
personality disorders childhood trauma |
| gptkbp:is_often_described_as |
repeated hospital visits
|
| gptkbp:is_often_hidden_from |
family and friends
|
| gptkbp:is_often_seen_in |
gptkb:conversion_disorder
caregivers |
| gptkbp:is_often_treated_by |
mental health professionals
|
| gptkbp:is_part_of |
health information systems
global health initiatives |
| gptkbp:is_promoted_by |
healthcare associations
|
| gptkbp:is_promoted_through |
healthcare conferences
|
| gptkbp:is_recognized_by |
international health organizations
|
| gptkbp:is_referenced_in |
gptkb:guidelines
gptkb:Health_Insurance healthcare policies |
| gptkbp:is_reviewed_by |
gptkb:academic_journals
gptkb:healthcare_professionals |
| gptkbp:is_supported_by |
research funding
government funding |
| gptkbp:is_targeted_at |
stressful life events
|
| gptkbp:is_updated_by |
several years
|
| gptkbp:is_used_by |
insurance companies
|
| gptkbp:is_used_for |
resource allocation
|
| gptkbp:is_used_in |
epidemiology
global health initiatives |
| gptkbp:is_used_to |
track disease outbreaks
|
| gptkbp:is_utilized_for |
research studies
statistical analysis public health research public health interventions billing purposes clinical documentation healthcare reimbursement |
| gptkbp:is_utilized_in |
clinical trials
healthcare audits |
| gptkbp:is_vulnerable_to |
gptkb:Anthrax_Vaccine_Adsorbed_(AVA)
inactivated vaccine 3 doses for primary series |
| gptkbp:key |
patient care
healthcare analytics healthcare interoperability |
| gptkbp:known_as |
gptkb:Munchausen_syndrome
|
| gptkbp:laboratory_finding |
low platelet count
elevated lactate dehydrogenase elevated creatinine low hemoglobin schistocytes in blood smear |
| gptkbp:latest_version |
gptkb:ICD-11
|
| gptkbp:lifespan |
normal with treatment
reduced without treatment |
| gptkbp:located_in |
various cities
|
| gptkbp:management |
supportive care
monitoring for complications |
| gptkbp:notable_abilities |
time travel
|
| gptkbp:number_of_players |
acute form occurs within 100 days post-transplant
affects 30-50% of allogeneic transplant recipients higher incidence in mismatched transplants incidence varies by donor type chronic form can occur after 100 days post-transplant |
| gptkbp:occurs_in |
other psychiatric disorders
common in allogeneic transplants |
| gptkbp:offers_programs_in |
gptkb:educational_programs
vaccination programs |
| gptkbp:origin |
Chronicle of the Chronicoms
|
| gptkbp:outcome |
can be life-threatening
may lead to chronic complications |
| gptkbp:pathway |
endothelial injury
thrombotic microangiopathy microangiopathic hemolytic anemia |
| gptkbp:prevalence |
1 in 40,000
|
| gptkbp:prevention |
vaccination
HLA matching proper food handling hand washing avoid contact with infected animals proper handling of animal products minimizing donor-recipient mismatch |
| gptkbp:provides |
standardized diagnostic criteria
|
| gptkbp:provides_guidance_on |
NCCN guidelines
EBMT guidelines |
| gptkbp:published_by |
multiple languages
|
| gptkbp:regulatory_compliance |
controlled substance in some countries
|
| gptkbp:related_to |
bone marrow transplant
stem cell transplant |
| gptkbp:replaced_by |
gptkb:ICD-11
|
| gptkbp:requires |
healthcare providers
multidisciplinary approach careful management |
| gptkbp:research |
antibiotic resistance
vaccine development studies on treatment efficacy pathogenesis studies ongoing studies on prevention |
| gptkbp:research_focus |
gptkb:gene_therapy
biomarkers new enzyme therapies |
| gptkbp:risk_factor |
elderly individuals
young children immunocompromised individuals older age female donor to male recipient previous transfusions |
| gptkbp:scientific_classification |
somatic symptom and related disorders
|
| gptkbp:services_provided |
consultation
diagnosis treatment |
| gptkbp:side_effect |
gptkb:significant
|
| gptkbp:specializes_in |
pediatric infectious diseases
|
| gptkbp:supports |
healthcare research
|
| gptkbp:symptoms |
gptkb:anemia
fatigue nausea cough fever sore throat vomiting diarrhea skin rash bone pain easy bruising enlarged liver enlarged spleen muscle aches acute kidney failure hemolytic anemia thrombocytopenia liver dysfunction chest discomfort |
| gptkbp:translated_into |
multiple languages
|
| gptkbp:transmission |
spores
|
| gptkbp:treatment |
gptkb:psychotherapy
gptkb:ciprofloxacin gptkb:Biology antibiotics improved quality of life supportive care corticosteroids reduced symptoms substrate reduction therapy plasma exchange immunosuppressive therapy doxycycline increased lifespan most recover fully early intervention improves prognosis spleen removal surgery some may have long-term effects medication for co-occurring conditions antithymocyte globulin dialysis may be required in severe cases kidney function may return to normal |
| gptkbp:type |
gptkb:Type_3
Type 1 Type 2 |
| gptkbp:type_of |
gptkb:cutaneous_anthrax
gptkb:inhalation_anthrax gptkb:injection_anthrax gptkb:chronic_graft-versus-host_disease gastrointestinal anthrax acute graft-versus-host disease |
| gptkbp:updated_to |
gptkb:ICD-11
|
| gptkbp:used_by |
gptkb:researchers
healthcare providers insurance companies |
| gptkbp:used_for |
health management
|
| gptkbp:used_in |
medical coding
|
| gptkbp:vaccine_use |
gptkb:military_personnel
high-risk individuals laboratory workers |
| gptkbp:was_educated_at |
medical training programs
|
| gptkbp:bfsParent |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:Demi_Lovato gptkb:Polo_G gptkb:Medicare gptkb:National_Institutes_of_Health gptkb:Biology gptkb:war |
| gptkbp:bfsLayer |
3
|